Relive the excitement of the Patriots’ path to their fourth Super Bowl Championship with “Pumped,” a special commemorative book from The Boston Globe.

Celtics Live

46

44

2nd Quarter 1:11

mass. movers

Curis stock plunges as drug trial stalls

Curis must provide more safety data to resume testing. Above, a cancer patient gets radiation treatment.

San Antonio Express-News via AP

Curis must provide more safety data to resume testing. Above, a cancer patient gets radiation treatment.

Continue reading below

Curis Inc., which is developing cancer therapies, plunged after the Lexington company unveiled quarterly results and an FDA action. Revenue swelled to $7.2 million, from less than $0.6 million a year earlier, and the net loss shrank by nearly half to $1.9 million. But Curis’s cancer drug CUDC-427 was put on partial hold by the FDA — negating any chance of enrolling new patients in a phase 1 study. A patient died of liver failure a month after the end of CUDC-427 treatment.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com